Critical issues of the biopsychosocial treatment of Parkinson's disease;A Parkinson-kór biopszichoszociális ellátásának kritikus kérdései

Orvosi Hetilap

Volumn 156, Issue 12, 2015, Pages 472-478

  Kincses, Péter ^a   Kovács, Norbert ^b   Karádi, Kázmér ^a   Kállai, János ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

Author keywords

biopsychosocial model; Parkinson's disease; psychoeducation; quality of life; rehabilitation

Indexed keywords

AFFECT; ARTICLE; BIOPSYCHOSOCIAL TREATMENT; COGNITION; HEALTH CARE SYSTEM; HUMAN; PARKINSON DISEASE; PSYCHOSOCIAL CARE; QUALITY OF LIFE; COGNITIVE THERAPY; FAMILY; MUSIC THERAPY; PATHOPHYSIOLOGY; PATIENT EDUCATION; PROCEDURES; PSYCHODRAMA; PSYCHOLOGY; PSYCHOTHERAPY; QUESTIONNAIRE; SOCIAL SUPPORT;

ANTIPARKINSON AGENT;

ANTIPARKINSON AGENTS; COGNITIVE THERAPY; FAMILY; HUMANS; MUSIC THERAPY; PARKINSON DISEASE; PATIENT EDUCATION AS TOPIC; PSYCHODRAMA; PSYCHOTHERAPY; QUALITY OF LIFE; QUESTIONNAIRES; SOCIAL SUPPORT;

EID: 84924940487     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2015.30109     Document Type: Article

References (45)

1. Braak, H., Del Tredici, K., Bratzke, H., et al.: Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages). J. Neurol., 2002, 249(3 Suppl.), iii1-iii5.
2. Kehagia, A. A., Barker, R. A., Robbins, T. W.: Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease. Lancet Neurol., 2010, 9(12), 1200-1213.
3. Rommelfanger, K. S., Weinshenker, D.: Norepinephrine: The redheaded stepchild of Parkinson's disease. Biochem. Pharmacol., 2007, 74(2), 177-190.
4. Braak, H., Rüb, U., Del Tredici, K.: Cognitive decline correlates with neuropathological stage in Parkinson's disease. J. Neurol. Sci., 2006, 248(1-2), 255-258.
5. Sharma, S., Moon, C. S., Khogali, A., et al.: Biomarkers in Parkinson's disease (recent update). Neurochem. Int., 2013, 63(3), 201-229.
6. Szirmai, I.: Neurology. [Neurológia.] Medicina Könyvkiadó, Budapest, 2001. [Hungarian]
7. Komoly, S., Palkovits, M.: Practical neurology and neuroanatomy. [Gyakorlati neurológia és neuroanatómia.] Medicina Könyvkiadó, Budapest, 2010. [Hungarian]
8. Herlofson, K., Larsen, J. P.: The influence of fatigue on healthrelated quality of life in patients with Parkinson's disease. Acta Neurol. Scand., 2003, 107(1), 1-6.
9. Singh, N., Pillay, V., Choonara, Y. E.: Advances in the treatment of Parkinson's disease. Prog. Neurobiol., 2007, 81(1), 29-44.
10. Antonini, A., Barone, P., Marconi, R., et al.: The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life. J. Neurol., 2012, 259(12), 2621-2631.
11. Truong, D. D., Bhidayasiri, R., Wolters, E.: Management of nonmotor symptoms in advanced Parkinson disease. J. Neurol. Sci., 2008, 266(1-2), 216-228.
12. Karádi, K., Lucza, T., Aschermann, Zs., et al.: Visuospatial impairment in Parkinson's disease: the role of laterality. Laterality, 2015, 20(1), 112-127
13. Sung, V. W., Nicholas, A. P.: Nonmotor symptoms in Parkinson's disease. Expanding the view of Parkinson's disease beyond a pure motor, pure dopaminergic problem. Neurol. Clin., 2013, 31(3), S1-S16.
14. Poewe, W.: Non-motor symptoms in Parkinson's disease. Eur. J. Neurol., 2008, 15(Suppl. 1), 14-20.
15. Varanese, S., Birnbaum, Z., Rossi, R., et al.: Treatment of advanced Parkinson's disease. Parkinsons Dis., 2010, 2010, 480260.
16. Mah, L., Zarate, C. A. Jr., Nugent, A. C., et al.: Neural mechanisms of antidepressant efficacy of the dopamine receptor agonist pramipexole in treatment of bipolar depression. Int. J. Neuropsychopharmacol., 2011, 14(4), 545-551.
17. Maj, J., Rogóz, Z., Skuza, G., et al.: Antidepressant effects of pramipexole, a novel dopamine receptor agonist. J. Neural. Transm., 1997, 104(4-5), 525-533.
18. Pal, E., Nagy, F., Aschermann, Z., et al.: The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson's disease: a randomized, double-blind, placebo-controlled study. Mov. Disord., 2010, 25(14), 2311-2317.
19. Kovács, N.: Evidence-based treatment of Parkinson's disease. [A Parkinson-kór evidenciákon alapuló kezelése]. Orvostovábbképz Szemle, 2011, 18(Klnsz., július), 11-17. [Hungarian]
20. Takáts, A., Nagy, H., Radics, P., et al.: Treatment possibilities in advanced Parkinson's disease. [Kezelési lehetségek a Parkinson kór elrehaladott stádiumában.] Ideggyogyaszati Szemle, 2013, 66(11-12), 365-371. [Hungarian]
21. Fehér, G., Balás, I., Komoly, S., et al.: Analysis of antiparkinsonian drug reduction after bilateral subthalamic deep brain stimulation. [A kétoldali subthalamicus stimuláció hatékonysága az antiparkinson gyógyszerelés változtatásának tükrében.] Ideggyogyaszati Szemle, 2010, 63(9-10), 314-319. [Hungarian]
22. Kovács, N., Balás, I., Janszky, J., et al.: Special aspects of patient care after implantation of deep brain stimulator. [A mélyagyi stimulátor beültetését követ beteggondozás speciális kérdései.] Ideggyogyaszati Szemle, 2008, 61(1-2), 4-15. [Hungarian]
23. Deli, G., Balás, I., Komoly, S., et al.: Earlier and more effective: Role of deep brain stimulation in preserving work capacity. [ Korábban és hatékonyabban: A mély agyi stimulációs szerepe a munkaképesség megrzésében.] Ideggyogyaszati Szemle, 2015, in press [Hungarian]
24. Deuschl, G., Schüpbach, M., Knudsen, K., et al.: Stimulation of the subthalamic nucleus at an earlier disease stage of Parkinson's disease: concept and standards of the EARLYSTIM-study. Parkinsonism Relat. Disord., 2013, 19(1), 56-61.
25. Bloem, B. R., Stocchi, F.: Move for change Part I: a European survey evaluating the impact of the EPDA Charter for People with Parkinson's disease. Eur. J. Neurol., 2012, 19(3), 402-410.
26. The European Parkinson's Disease Standards of Care Consensus Statement. Volume II. EPDA, London, 2012.
27. Sammer, G., Reuter, I., Hullmann, K., et al.: Training of executive functions in Parkinson's disease. J. Neurol. Sci., 2006, 248(1-2), 115-119.
28. Reuter, I., Mehnert, S., Oechsner, M., et al.: Cognitive rehabilitation in Parkinson's disease using neuropsychological training, transfer training and sports therapy. In. Dushanova, J. (ed.): Diagnostics and Rehabilitation of Parkinson's Disease. In Tech, Rijeka, 2011.
29. Kállai, J.: Health and social support. In: Kállai, J., Varga, J., Oláh, A. (eds.): Health psychology in practice. [Egészség és társas támogatás. In: Kállai, J., Varga, J., Oláh, A. (szerk.): Egészségpszichológia a gyakorlatban.] Medicina Könyvkiadó, Budapest, 2007. [Hungarian]
30. Kerekes, Zs., Kállai, J.: Social support, social integration, singleness and intimacy. In: Kállai, J., Kaszás, B., Tiringer, I. (eds.): Health psychology of elderly. [Társas támogatás, szociális integráció, magány és intimitás az idskorban. In: Kállai, J., Kaszás, B., Tiringer, I. (szerk.): Az idskorúak egészségpszichológiája.] Medicina Könyvkiadó, Budapest, 2013. [Hungarian]
31. Goldenberg, H., Goldenberg, I.: Review on Family. Vol. 1. [Ättekintés a családról. I. kötet.] Animula Kiadó, Budapest, 2008. [Hungarian]
32. Sproesser, E., Viana, M. A., Quagliato, E. M., et al.: The effect of psychotherapy in patients with PD: A controlled study. Parkinsonism Relat. Dis., 2010, 16(4), 298-300.
33. Fazekas, G., Kulmann, L.: Adaptation of the quality of life questionnary for patients with Parkinson's disease (PDQ-39) in Hungary. [Parkinsonos betegek életminségét vizsgáló kérdív (PDQ-39) magyarországi adaptációja.] Ideggyogyaszati Szemle, 2001, 54(1-2), 42-44. [Hungarian]
34. Verseghi, A.: Interpersonal context of neuropsychologic examination. In: Kállai, J., Bende, I., Karádi, K., et al. (eds.): Introduction to neuropsychology. [A neuropszichológiai vizsgálat interperszonális kontextusa. In: Kállai, J., Bende, I., Karádi, K., et al. (szerk.): Bevezetés a neuropszichológiába.] Medicina Könyvkiadó, Budapest, 2008. [Hungarian]
35. Kádári, K., Horváth, D., Kállai, J.: Psychotherapeutic background of the rehabilitation of patients with traumatic brain injury. [Traumás agysérültek rehabilitációjának pszichoterápiás háttere.] Pszichoterápia, 2011, 20(1), 23-32. [Hungarian]
36. Calleo, J., Burrows, C., Levin, H., et al.: Cognitive rehabilitation for executive dysfunction in Parkinson's disease: application and current direction. Parkinson's Dis., 2012, 2012, 512892.
37. Bereznai, B., Molnár, M. J.: Genetics and present therapy options in Parkinson's disease: a review. [A Parkinson-kór genetikája és aktuális terápiás lehetségei.] Ideggyogyaszati Szemle, 2009, 62(5-6), 155-163. [Hungarian]
38. Cully, J. A., Teten, A. L.: A Therapist's Guide to Brief Cognitive Behavioral Therapy. Department of Veterans Affairs, South Central MIRECC, Houston, 2008.
39. Farabaugh, A., Locascio, J. J., Yap, L., et al.: Cognitive-behavioral therapy for patients with Parkinson's disease and comorbid major depressive disorder. Psychosomatics, 2010, 51(2), 124-129.
40. Charlton, G. S., Barrow, C. J.: Coping and self-help group membership in Parkinson's disease: an exploratory qualitative study. Health Soc. Care Community, 2002, 10(6), 472-478.
41. Pacchetti, C., Mancini, F., Aglieri, R., et al.: Active music therapy in Parkinson's disease: an integrative method for motor and emotional rehabilitation. Psychosom. Med., 2000, 62(3), 386-393.
42. Marwick, C.: Leaving concert hall for clinic, therapists now test music's 'charms.' JAMA, 1996, 275(4), 267-268.
43. Barnason, S., Zimmerman, L., Nieveen, J.: The effects of music interventions on anxiety in the patient after coronary artery bypass grafting. Heart Lung, 1995, 24(2), 124-132.
44. A'Campo, L. E., Spliethoff-Kamminga, N. G., Macht, M., et al.: Caregiver education in Parkinson's disease: formative evaluation of a standardized program in seven European countries. Qual. Life Res., 2010, 19(1), 55-64.
45. Macht, M., Gerlich, C., Ellgring, H., et al.: Patient education in Parkinson's disease: Formative evaluation of a standardized programme in seven European countries. Patient Educ. Couns., 2007, 65(2), 245-252.